1998
Suppression of matrix metalloproteinase-2-mediated cell invasion in U87MG, human glioma cells by anti-microtubule agent: in vitro study
Yoshida D, Piepmeier J, Bergenheim T, Henriksson R, Teramoto A. Suppression of matrix metalloproteinase-2-mediated cell invasion in U87MG, human glioma cells by anti-microtubule agent: in vitro study. British Journal Of Cancer 1998, 77: 21-25. PMID: 9459141, PMCID: PMC2151249, DOI: 10.1038/bjc.1998.4.Peer-Reviewed Original ResearchConceptsMatrix metalloproteinase-2Dose-dependent mannerEstramustine groupMetalloproteinase-2Glioma cellsCell invasionMalignant glioma cellsHuman glioma cellsAnti-microtubule agentsControl groupEstramustineMatrix metalloproteinasesInfiltrative capacityCell invasivenessAntimicrotubule agentsCell proliferationSignificant suppressionDisassembly of microtubulesSignificant differencesU87MG cellsLower ratesInvasionHaptoinvasionCellsGroup
1986
The Spinal Cord Injury Problem—A Review
COLLINS W, PIEPMEIER J, OGLE E. The Spinal Cord Injury Problem—A Review. Journal Of Neurotrauma 1986, 3: 317-331. PMID: 3555851, DOI: 10.1089/cns.1986.3.317.Peer-Reviewed Original ResearchConceptsSpinal cord injuryCord injuryClinical trialsSingle randomized clinical trialCentral nervous system injuryRandomized clinical trialsNervous system injuryNeurological outcomeNeurological deficitsSteroid treatmentSecondary injuryNeurological functionSystem injuryTreatment regimensClinical seriesSpinal cordLow doseHigh doseTherapeutic goalsTherapeutic effectivenessInjuryInjury problemSocietal costsSignificant differencesBiochemical changes